PECAM1 and neoplasm: To further validate whether the reduced in vivo tumor neovascularization involves blockade of ERK activity by NYG, we co-stained the blood vessel network in tumor stroma with CD31 and phosphorylated-ERK (p-ERK) before being subjected to confocal microscopy analysis.